Unconditioned response to an aversive stimulus as predictor of response to conditioned fear and safety: A cross-species study.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 12 08 2020
revised: 23 11 2020
accepted: 23 12 2020
pubmed: 9 1 2021
medline: 28 12 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

Safety signals predict the non-occurrence of an aversive event, thereby inhibiting fear responses. Previous research has shown that conditioned safety learning is impaired in patients suffering from post-traumatic stress disorder (PTSD). Using a translational approach, the present study aimed to investigate whether individual responses to an aversive unconditioned stimulus (US) in rats (basic science), non-traumatized (pre-clinical) or traumatized humans (clinical) predicts their response to a conditioned fear or safety stimulus. Using three different archival datasets, the unconditioned response (UCR) to the US during fear or safety conditioning was assessed in rats, non-traumatized humans, and trauma-exposed humans. The response to learned fear (CS+; context) and safety (CS-) was measured by the modulation of the startle response (rats, traumatized humans) or skin conductance response (non-traumatized humans). Our results showed that all groups with low UCR and those with high UCR from the rodent or non-traumatized human samples displayed lower fear response to the CS- than to the CS+ . Traumatized humans with high UCR showed similarly high responses to the CS+ and CS-. While all groups showed a positive association between the UCR and CS+ response, the UCR correlated positively with the CS- response in traumatized humans only. Our findings suggest that an elevated response to aversive stimuli predicts deficits in conditioned safety memory in those at risk for trauma-related disorders and confirms that impaired safety learning could be a valid biomarker for these diseases.

Identifiants

pubmed: 33417995
pii: S0166-4328(20)30804-4
doi: 10.1016/j.bbr.2020.113105
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113105

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Judith C Kreutzmann (JC)

Institute for Pharmacology & Toxicology, Otto-von-Guericke University Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany; Department of Psychiatry & Behavioral Neurosciences, Wayne State University Detroit, Michigan, United States.

Marie-France Marin (MF)

Research Center of the Montreal Mental Health University Institute, Canada; Department of Psychology, Université du Québec à Montréal, Canada.

Markus Fendt (M)

Institute for Pharmacology & Toxicology, Otto-von-Guericke University Magdeburg, Germany; Center for Behavioral Brain Sciences, Otto-von-Guericke University Magdeburg, Germany.

Mohammed R Milad (MR)

Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, United States.

Kerry Ressler (K)

Department of Psychiatry, Harvard University, Boston, MA, United States.

Tanja Jovanovic (T)

Department of Psychiatry, Harvard University, Boston, MA, United States; Department of Psychiatry & Behavioral Neurosciences, Wayne State University Detroit, Michigan, United States. Electronic address: tjovanovic@med.wayne.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH